COEGIN PHARMACOEGIN PHARMACOEGIN PHARMA

COEGIN PHARMA

No trades
See on Supercharts
Market capitalization
‪96.02 M‬SEK
−1.86SEK
‪−27.98 M‬SEK
0.00SEK
Beta (1Y)
0.79

About COEGIN PHARMA


CEO
Jens Eriksson
Headquarters
Lund
Founded
2016
ISIN
SE0020357754
FIGI
BBG00JDRC616
Coegin Pharma AB is a biotechnology company with projects in hair growth, skin pigmentation, myocardial infarction, leukemia. What the projects have in common is that they are based on validated technology platforms and collaborations with researchers and academics internationally. Coegin Pharma was founded in 2005 and is headquartered in Lund, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of COEGIN is 3.91 SEK — it has decreased by −1.01% in the past 24 hours. Watch COEGIN PHARMA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange COEGIN PHARMA stocks are traded under the ticker COEGIN.
COEGIN stock has fallen by −1.76% compared to the previous week, the month change is a −8.00% fall, over the last year COEGIN PHARMA has showed a −28.91% decrease.
We've gathered analysts' opinions on COEGIN PHARMA future price: according to them, COEGIN price has a max estimate of 9.00 SEK and a min estimate of 9.00 SEK. Watch COEGIN chart and read a more detailed COEGIN PHARMA stock forecast: see what analysts think of COEGIN PHARMA and suggest that you do with its stocks.
COEGIN reached its all-time high on Mar 22, 2018 with the price of 263.39 SEK, and its all-time low was 1.16 SEK and was reached on Apr 15, 2020. View more price dynamics on COEGIN chart.
See other stocks reaching their highest and lowest prices.
COEGIN stock is 14.33% volatile and has beta coefficient of 0.79. Track COEGIN PHARMA stock price on the chart and check out the list of the most volatile stocks — is COEGIN PHARMA there?
Today COEGIN PHARMA has the market capitalization of ‪96.02 M‬, it has increased by 4.29% over the last week.
Yes, you can track COEGIN PHARMA financials in yearly and quarterly reports right on TradingView.
COEGIN net income for the last quarter is ‪−5.71 M‬ SEK, while the quarter before that showed ‪−4.45 M‬ SEK of net income which accounts for −28.22% change. Track more COEGIN PHARMA financial stats to get the full picture.
No, COEGIN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, COEGIN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COEGIN PHARMA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COEGIN PHARMA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COEGIN PHARMA stock shows the sell signal. See more of COEGIN PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.